IN2014MN00971A - - Google Patents
Info
- Publication number
- IN2014MN00971A IN2014MN00971A IN971MUN2014A IN2014MN00971A IN 2014MN00971 A IN2014MN00971 A IN 2014MN00971A IN 971MUN2014 A IN971MUN2014 A IN 971MUN2014A IN 2014MN00971 A IN2014MN00971 A IN 2014MN00971A
- Authority
- IN
- India
- Prior art keywords
- producing
- formula
- alkyl group
- acceptable salt
- raw material
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 abstract 2
- YLXPJOGZAZORTI-WGWCYKRDSA-N (4S,5R,6R)-5-acetamido-2,4-dihydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid dihydrate Chemical compound O.O.CC(=O)N[C@@H]1[C@@H](O)CC(O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO YLXPJOGZAZORTI-WGWCYKRDSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- BQINXKOTJQCISL-GRCPKETISA-N keto-neuraminic acid Chemical class OC(=O)C(=O)C[C@H](O)[C@@H](N)[C@@H](O)[C@H](O)[C@H](O)CO BQINXKOTJQCISL-GRCPKETISA-N 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/14—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011275819 | 2011-12-16 | ||
| PCT/JP2012/082294 WO2013089168A1 (ja) | 2011-12-16 | 2012-12-13 | ノイラミン酸誘導体の製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN00971A true IN2014MN00971A (enrdf_load_html_response) | 2015-05-22 |
Family
ID=48612610
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN971MUN2014 IN2014MN00971A (enrdf_load_html_response) | 2011-12-16 | 2012-12-13 |
Country Status (12)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104418876B (zh) * | 2013-09-09 | 2019-05-17 | 中国科学院上海有机化学研究所 | 扎那米韦和拉那米韦的中间体及其合成方法 |
| CN113801138B (zh) * | 2020-06-12 | 2024-11-29 | 博瑞生物医药（苏州）股份有限公司 | 一种一锅法制备辛酸拉尼米韦中间体的方法 |
| CN113801082B (zh) * | 2020-06-12 | 2024-09-17 | 博瑞生物医药（苏州）股份有限公司 | 一种辛酸拉尼米韦的制备方法 |
| KR102405310B1 (ko) * | 2020-07-08 | 2022-06-02 | 가톨릭대학교 산학협력단 | 유체의 압력을 이용한 인공 요도괄약근 |
| CN114907301B (zh) * | 2021-02-10 | 2024-05-28 | 上海医药工业研究院 | 一种拉尼米韦辛酸酯中间体及其制备方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5141897B2 (enrdf_load_html_response) * | 1972-11-30 | 1976-11-12 | ||
| JP2745059B2 (ja) * | 1989-03-08 | 1998-04-28 | メクト株式会社 | Ｎ―アセチルノイラミン酸ナトリウム・三水和物 |
| GB9325841D0 (en) * | 1993-12-17 | 1994-02-23 | Glaxo Group Ltd | Chemical compounds |
| JPH0994768A (ja) * | 1995-09-29 | 1997-04-08 | Nippon Electric Ind Co Ltd | 車用電動工具 |
| US6451766B1 (en) * | 1996-07-22 | 2002-09-17 | Sankyo Company, Limited | Neuraminic acid derivatives, their preparation and their medical use |
| US6340702B1 (en) | 1996-07-22 | 2002-01-22 | Sankyo Company, Limited | Neuraminic acid derivatives, their preparation and their medical use |
| JP3209946B2 (ja) | 1996-07-22 | 2001-09-17 | 三共株式会社 | ノイラミン酸誘導体 |
| DE69709795T2 (de) * | 1996-07-22 | 2002-09-26 | Sankyo Co., Ltd. | Neuraminsäuredervate, ihre Herstellung und medizinische Verwendung |
| US7330875B1 (en) | 1999-06-15 | 2008-02-12 | Microsoft Corporation | System and method for recording a presentation for on-demand viewing over a computer network |
| TWI291462B (en) * | 2000-04-25 | 2007-12-21 | Daiichi Sankyo Co Ltd | Hydrate crystal of neuraminic acid compound |
| AU2001252578A1 (en) | 2000-04-25 | 2001-11-07 | Sankyo Company Limited | Preventives for influenza |
| JP3920041B2 (ja) | 2000-04-25 | 2007-05-30 | 三共株式会社 | ノイラミン酸化合物の水和物及び結晶 |
| JP4205314B2 (ja) | 2000-04-25 | 2009-01-07 | 第一三共株式会社 | インフルエンザ予防剤 |
| TWI389895B (zh) * | 2006-08-21 | 2013-03-21 | Infinity Discovery Inc | 抑制ｂｃｌ蛋白質與結合夥伴間之交互作用的化合物及方法 |
| HRP20110861T1 (hr) * | 2007-03-07 | 2011-12-31 | Daiichi Sankyo Company | Lijek za liječenje gripe |
| TWI460182B (zh) * | 2007-04-11 | 2014-11-11 | Daiichi Sankyo Co Ltd | 原酸酯之製造方法 |
| TWI491416B (zh) * | 2008-12-24 | 2015-07-11 | Daiichi Sankyo Co Ltd | 吸入用乾燥粉末醫藥組成物 |
| CN102050771A (zh) * | 2009-11-05 | 2011-05-11 | 沈阳万爱普利德医药科技有限公司 | 一个一种前列腺素衍生物的制造方法 |
-
2012
- 2012-12-13 KR KR1020147016077A patent/KR101971311B1/ko active Active
- 2012-12-13 US US14/365,951 patent/US20140356625A1/en not_active Abandoned
- 2012-12-13 EP EP15174323.4A patent/EP2960237A1/en not_active Withdrawn
- 2012-12-13 ES ES15174321.8T patent/ES2640001T3/es active Active
- 2012-12-13 CN CN201510314653.1A patent/CN105037309A/zh active Pending
- 2012-12-13 CA CA2859296A patent/CA2859296C/en not_active Expired - Fee Related
- 2012-12-13 CN CN201510314576.XA patent/CN104926802B/zh active Active
- 2012-12-13 JP JP2013549304A patent/JP6038808B2/ja active Active
- 2012-12-13 EP EP15174321.8A patent/EP2960236B1/en active Active
- 2012-12-13 IN IN971MUN2014 patent/IN2014MN00971A/en unknown
- 2012-12-13 CN CN201280062083.6A patent/CN103974945B/zh active Active
- 2012-12-13 BR BR112014014635A patent/BR112014014635A2/pt not_active IP Right Cessation
- 2012-12-13 HK HK14112666.2A patent/HK1199034A1/en unknown
- 2012-12-13 WO PCT/JP2012/082294 patent/WO2013089168A1/ja active Application Filing
- 2012-12-13 EP EP12858308.5A patent/EP2792676A4/en not_active Withdrawn
-
2014
- 2014-06-15 IL IL233124A patent/IL233124A0/en unknown
- 2014-12-17 HK HK16106872.2A patent/HK1218911A1/en unknown
- 2014-12-17 HK HK16106875.9A patent/HK1218912A1/en unknown
-
2015
- 2015-01-18 IL IL236766A patent/IL236766A0/en unknown
-
2017
- 2017-01-09 US US15/401,665 patent/US20170114035A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2960237A1 (en) | 2015-12-30 |
| JP6038808B2 (ja) | 2016-12-07 |
| CN105037309A (zh) | 2015-11-11 |
| KR20140102216A (ko) | 2014-08-21 |
| BR112014014635A2 (pt) | 2017-06-13 |
| US20170114035A1 (en) | 2017-04-27 |
| ES2640001T3 (es) | 2017-10-31 |
| CN103974945A (zh) | 2014-08-06 |
| EP2792676A4 (en) | 2015-10-07 |
| EP2960236B1 (en) | 2017-06-14 |
| CN103974945B (zh) | 2016-03-09 |
| HK1199034A1 (en) | 2015-06-19 |
| EP2960236A1 (en) | 2015-12-30 |
| JPWO2013089168A1 (ja) | 2015-04-27 |
| HK1218911A1 (en) | 2017-03-17 |
| WO2013089168A1 (ja) | 2013-06-20 |
| EP2792676A1 (en) | 2014-10-22 |
| HK1218912A1 (en) | 2017-03-17 |
| US20140356625A1 (en) | 2014-12-04 |
| CA2859296A1 (en) | 2013-06-20 |
| CN104926802B (zh) | 2018-02-13 |
| KR101971311B1 (ko) | 2019-04-22 |
| CN104926802A (zh) | 2015-09-23 |
| CA2859296C (en) | 2016-10-11 |
| IL236766A0 (en) | 2015-03-31 |
| IL233124A0 (en) | 2014-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2015005286A (es) | Procedimiento para la preparación de derivados del ácido biliar. | |
| PH12017501429A1 (en) | Derivatives of betulin | |
| PH12012500634A1 (en) | Processes for preparing of glucopyranosyl -substituted benzyl -benzene derivatives | |
| PT2411395E (pt) | Derivados de furopirimidinadiona como moduladores de trpa1 | |
| MX2012003343A (es) | Proceso para preparar compuestos azabiciclicos. | |
| MD20180040A2 (ro) | Inhibitori ai virusului hepatic C | |
| MX2013011257A (es) | Proceso para la preparacion de dronedarona por n-butilacion. | |
| PH12015501226A1 (en) | Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing the same | |
| NZ603268A (en) | Process for synthesizing oxidized lactam compounds | |
| UA111142C2 (uk) | Одержання заміщених похідних 2-фторакрилової кислоти | |
| EP2590649A4 (en) | PROCESS FOR SYNTHESIS OF SUBSTITUTED MORPHINANES | |
| IN2014CN04449A (enrdf_load_html_response) | ||
| MX2011009898A (es) | Proceso para la obtencion de derivados de acido propionico. | |
| WO2013014665A8 (en) | Intermediate compounds and process for the preparation of lurasidone and salts thereof | |
| IN2014DN00144A (enrdf_load_html_response) | ||
| MX2012001411A (es) | Proceso para la preparacion de derivados de acido 1-(2-halobifenil-4-il)-ciclopropanocarboxilico. | |
| IN2014MN00971A (enrdf_load_html_response) | ||
| MX2014004688A (es) | Proceso de obtencion de acidos isoxazolil-metoxi-nicotinicos. | |
| WO2012140490A3 (en) | Processes for preparing pitavastatin calcium | |
| MX364529B (es) | Nuevos ligandos del receptor de estrógeno. | |
| IN2014DN09451A (enrdf_load_html_response) | ||
| WO2013072938A3 (en) | Process for the preparation of roflumilast | |
| MX2013004193A (es) | Procedimiento para la preparacion de derivados de acido 3-(6-amino-piridin-3-il)-2-acrilico. | |
| IN2012DN02000A (enrdf_load_html_response) | ||
| MX369283B (es) | Preparacion de 2-amino-5-ciano-n, 3-dimetilbenzamida. |